IL17RA and dry eye syndrome: Most notably, Il-17R:Fc gene therapy dramatically reduced expression of Klk1b22, which has been shown to be sufficient to cause keratoconjunctivitis sicca (KCS) when used to inoculate healthy Lewis rats [14].